BioCryst
Medical AFFAIRS
Navigate the Biocryst Medical Affairs Hub with ease
Throughout this resource hub you will find up-to-date information on developing and approved BioCryst medicines, including clinical trials, congress information, published data, and other research material.
Search for medical information
Find information on BioCryst products.
Find information
on upcoming and previous congresses
Upcoming Congress Events
American College of Allergy, Asthma and Immunology (ACAAI)
BioCryst will attend the 2026 American College of Allergy, Asthma and Immunology (ACAAI) from Nov 12 – Nov 16, 2026.
Visit the Congress Website for More Information
Materials From Recent Congresses
Showing 144 Materials
-
Reductions in Healthcare Utilization Among Individuals with HAE Who Switched to Berotralstat from Another Prophylaxis
ACAAI | 2026 | HAE -
Hospitalization and Emergency Department Reductions After Initiating Berotralstat, Lanadelumab, or Subcutaneous Plasma-Derived-C1-Inhibitor for Hereditary Angioedema
ACAAI | 2026 | HAE -
Growth-Related Berotralstat Dose Adjustment in Children with Hereditary Angioedema: 48-Week Dosing Experience from APeX-P
ACAAI | 2026 | HAE -
Long-term Safety, Efficacy, and Quality of Life with Navenibart in Hereditary Angioedema: ALPHA-SOLAR Interim Results
ACAAI | 2026 | HAE -
Clinical Outcomes With Navenibart According to Baseline Attack Rate, Body Mass Index, and Age: Results of the ALPHA-STAR Trial
EAACI | 2026 | HAE
Current clinical trials and research
Learn more about medicines being developed at BioCryst and see the latest studies.
Discover more about our areas of focus
See our video library
Learn more about research within our areas of focus.
Ready to connect or have a question?
Have questions about any of our medicines that are approved or in development, or would you like to be connected with an MSL?
Have questions about our company?